Neuroendocrine function in transgenic male mice with human growth hormone expression.
The neuroendocrine effects of human growth hormone (hGH) secretion were studied in adult male mice into which an hGH gene fused with mouse metallothionein 1 (mMT-1) promoter had been introduced. Intact transgenic mice had significantly greater plasma luteinizing hormone (LH) levels than did normal littermate controls. Castration increased LH levels in normal mice but was without effect on plasma LH levels in the transgenic mice. In vitro LH secretion and pituitary LH content were higher in the intact transgenic mice than in intact controls, while there was no significant difference in pituitary LH levels and in vitro LH secretion between the 2 groups of castrate animals. Intact transgenic mice exhibited a greater median eminence (ME) norepinephrine (NE) turnover than control animals, but ME NE turnover did not increase after castration in the transgenic animals as was the case in control mice. Castrate mice expressing the hGH gene had plasma levels of prolactin (PRL) similar to those seen in castrate controls, which was unexpected based on a previous study showing greatly attenuated PRL levels in intact hGH mice when compared to intact controls from the same line. Dopamine (DA) turnover in the ME was not significantly affected by the presence of the hGH gene, suggesting that the difference in plasma PRL levels between normal and transgenic mice is mediated through changes in PRL-regulating factors other than DA. In conclusion, the expression of the mMT-1/hGH hybrid gene in male mice leads to major alterations in LH secretion and lesser changes in PRL secretion.(ABSTRACT TRUNCATED AT 250 WORDS)
Steger
R W
RW
Department of Physiology, School of Medicine, Southern Illinois University, Carbondale.
Bartke
A
A
Parkening
T A
TA
Collins
T
T
Yun
J S
JS
Wagner
T E
TE
D000818:Animals; D003001:Cloning, Molecular; D004298:Dopamine / Q000378:metabolism; D013006:Growth Hormone / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D007033:Hypothalamus, Middle / Q000378:metabolism / Q000502:physiology*; D066298:In Vitro Techniques; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D008473:Median Eminence / Q000378:metabolism; D008668:Metallothionein / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D009638:Norepinephrine / Q000378:metabolism; D009919:Orchiectomy; D009929:Organ Size / Q000502:physiology; D010903:Pituitary Gland, Anterior / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology*; D011388:Prolactin / Q000378:metabolism; D011401:Promoter Regions, Genetic
D011388:Prolactin; D007986:Luteinizing Hormone; D013006:Growth Hormone; D008668:Metallothionein; D004298:Dopamine; D009638:Norepinephrine